Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate

This study confirmed that TT in 40% PG given intratumorally as a single bolus dose was the most efficacio us treatment for a tongue SCC mouse model.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research